Northern Trust’s Blueprint Medicines BPMC Stock Holding History

Northern Trust’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-568,924	Closed	-$72.9M	–	4440
2025 Q2	$72.9M	Sell	568,924 -20,635	-4%	-$2.14M	0.01%	866
2025 Q1	$52.2M	Sell	589,559 -18,833	-3%	-$1.84M	0.01%	1058
2024 Q4	$53.1M	Buy	608,392 +52,574	+9%	+$4.82M	0.01%	1088
2024 Q3	$51.4M	Buy	555,818 +11,941	+2%	+$1.19M	0.01%	1007
2024 Q2	$58.6M	Sell	543,877 -15,013	-3%	-$1.5M	0.01%	905
2024 Q1	$53M	Sell	558,890 -14,610	-3%	-$1.25M	0.01%	950
2023 Q4	$52.9M	Sell	573,500 -14,960	-3%	-$969K	0.01%	971
2023 Q3	$29.6M	Buy	588,460 +2,763	+0.5%	+$148K	0.01%	1290
2023 Q2	$37M	Buy	585,697 +8,071	+1%	+$439K	0.01%	1168
2023 Q1	$26M	Buy	577,626 +19,738	+4%	+$889K	0.01%	1384
2022 Q4	$24.4M	Buy	557,888 +3,055	+0.6%	+$147K	0.01%	1407
2022 Q3	$36.6M	Sell	554,833 -1,629	-0.3%	-$105K	0.01%	1055
2022 Q2	$28.1M	Sell	556,462 -23,485	-4%	-$1.38M	0.01%	1303
2022 Q1	$37M	Sell	579,947 -105,722	-15%	-$7.59M	0.01%	1241
2021 Q4	$73.4M	Sell	685,669 -19,903	-3%	-$2.08M	0.01%	838
2021 Q3	$72.5M	Sell	705,572 -10,388	-1%	-$967K	0.01%	822
2021 Q2	$63M	Buy	715,960 +70,700	+11%	+$6.48M	0.01%	942
2021 Q1	$62.7M	Sell	645,260 -42,955	-6%	-$4.29M	0.01%	945
2020 Q4	$77.2M	Sell	688,215 -18,109	-3%	-$1.91M	0.02%	776
2020 Q3	$65.5M	Sell	706,324 -31,810	-4%	-$2.45M	0.01%	751
2020 Q2	$57.6M	Buy	738,134 +40,885	+6%	+$2.77M	0.01%	790
2020 Q1	$40.8M	Buy	697,249 +60,313	+9%	+$3.88M	0.01%	888
2019 Q4	$51M	Sell	636,936 -9,132	-1%	-$684K	0.01%	1005
2019 Q3	$47.5M	Buy	646,068 +48,702	+8%	+$4.21M	0.01%	1017
2019 Q2	$56.3M	Buy	597,366 +75,470	+14%	+$6.23M	0.01%	906
2019 Q1	$41.8M	Buy	521,896 +17,548	+3%	+$1.3M	0.01%	1104
2018 Q4	$27.2M	Sell	504,348 -16,508	-3%	-$1M	0.01%	1317
2018 Q3	$40.7M	Buy	520,856 +20,945	+4%	+$1.46M	0.01%	1185
2018 Q2	$31.7M	Buy	499,911 +2,776	+0.6%	+$221K	0.01%	1390
2018 Q1	$45.6M	Buy	497,135 +726	+0.1%	+$62.6K	0.01%	1058
2017 Q4	$37.4M	Buy	496,409 +29,267	+6%	+$2.06M	0.01%	1234
2017 Q3	$32.5M	Sell	467,142 -6,403	-1%	-$342K	0.01%	1315
2017 Q2	$24M	Buy	473,545 +167,044	+55%	+$7.09M	0.01%	1538
2017 Q1	$12.3M	Buy	306,501 +62,008	+25%	+$2.22M	﹤0.01%	1972
2016 Q4	$6.86M	Buy	244,493 +7,126	+3%	+$215K	﹤0.01%	2344
2016 Q3	$7.05M	Buy	237,367 +24,054	+11%	+$598K	﹤0.01%	2291
2016 Q2	$4.32M	Buy	213,313 +100,524	+89%	+$1.83M	﹤0.01%	2551
2016 Q1	$2.04M	Buy	112,789 +2,247	+2%	+$39K	﹤0.01%	2968
2015 Q4	$2.91M	Buy	110,542 +4,227	+4%	+$95.2K	﹤0.01%	2818
2015 Q3	$2.27M	Buy	106,315 +78,252	+279%	+$2.16M	﹤0.01%	2976
2015 Q2	$744K	Buy	+28,063	New	+$801K	﹤0.01%	3437

Other funds holding BPMC

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Northern Trust's BPMC Position: Q3 2025 in Review

Northern Trust sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 568,924 shares — an estimated $72.9M sold.

Northern Trust first reported a position in BPMC in Q2 2015 and held it in 41 quarters. The position peaked at $77.2M in Q4 2020. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

Northern Trust reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
Northern Trust sold 568,924 Blueprint Medicines shares in Q3 2025, an estimated $72.9M.
Northern Trust first reported a position in Blueprint Medicines in Q2 2015 and held it in 41 quarters.
Northern Trust's Blueprint Medicines position peaked at $77.2M in Q4 2020.
5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Northern Trust's 13F filing for Q3 2025, filed 14 Nov 2025.